| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.27B | 23.43B | 23.84B | 23.33B | 18.62B | 14.68B |
| Gross Profit | 2.00B | 2.58B | 1.74B | 2.65B | 2.24B | 1.39B |
| EBITDA | 741.00M | 1.32B | 467.00M | 1.24B | 977.00M | 430.00M |
| Net Income | 397.00M | 953.00M | 200.00M | 986.00M | 1.02B | 138.00M |
Balance Sheet | ||||||
| Total Assets | 63.27B | 72.94B | 64.18B | 58.52B | 50.72B | 49.04B |
| Cash, Cash Equivalents and Short-Term Investments | 6.55B | 7.02B | 6.87B | 3.20B | 8.29B | 11.72B |
| Total Debt | 3.58B | 4.20B | 4.70B | 830.00M | 807.00M | 740.00M |
| Total Liabilities | 19.67B | 22.66B | 20.91B | 13.94B | 12.43B | 11.93B |
| Stockholders Equity | 43.60B | 50.27B | 43.27B | 44.58B | 38.29B | 37.10B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 918.00M | 1.95B | -5.68B | -3.32B | 866.00M |
| Operating Cash Flow | 0.00 | 1.02B | 4.27B | -3.85B | -1.40B | 2.12B |
| Investing Cash Flow | 0.00 | 2.00M | -3.14B | -928.00M | -714.00M | -1.81B |
| Financing Cash Flow | 0.00 | -838.00M | 2.59B | -300.00M | -321.00M | 444.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥15.85B | 8.54 | ― | 3.71% | -8.81% | 2.81% | |
68 Neutral | ¥11.74B | 5.65 | ― | 1.01% | -13.50% | 22.11% | |
67 Neutral | ¥15.31B | 6.38 | ― | 3.03% | 24.82% | 23.42% | |
65 Neutral | ¥16.05B | 15.63 | ― | 1.39% | -1.70% | 409.83% | |
65 Neutral | ¥15.19B | 7.78 | ― | 3.68% | -9.66% | 22.05% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥110.27B | 12.80 | ― | 3.81% | -9.72% | -31.50% |